CareDx Inc (CDNA) - התחייבויות לטווח ארוך להון

CareDx, Inc (CDNA) specializes in transplant diagnostics, optimizing costs through a single laboratory center for the entire country. Efficiency is enhanced by implementing robots for high-precision DNA sequencing, which eliminates manual labor. However, changes in Medicare reimbursement rules create risks for margins, despite legal protections. The current indicator stands at 0.03, which clearly demonstrates the market trend visualized in monetary format.

Recurring revenues for CareDx, Inc (CDNA) from lifelong transplant monitoring ensure high cash flow stability, minimizing risks associated with debt servicing. By analyzing the long-term financial leverage ratio, an investor can see the ratio of liabilities with a maturity of over one year to equity, which allows for an assessment of the business's dependence on external borrowing and its overall stress resilience.